Roche, Hansoh Launch Up-to-$15B+ Cancer ADC Collaboration
The companies' strategic collaboration will consist of two preclinical Hansoh ADC programs and “multiple” ADC programs based on Roche-identified targets, to be developed through Hansoh’s ADC technology platform.